ESC 365 - RNAi inhibition of angiopoietin-like protein 3 (ANGPTL3) with ARO-ANG3 mimics the lipid and lipoprotein profile of familial combined hypolipidemia

ESC Premium Access

RNAi inhibition of angiopoietin-like protein 3 (ANGPTL3) with ARO-ANG3 mimics the lipid and lipoprotein profile of familial combined hypolipidemia

Session: Novel Approaches to Lipid Lowering Therapy

Topic: Lipid-Lowering Agents

Speaker: Professor G. Watts (Perth, AU)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Gerald Watts

University of Western Australia, Perth (Australia)

2 presentations

0 follower

2 more presentations in this session

RNA interference targeting apolipoprotein C-III with ARO-APOC3 in healthy volunteers mimics lipid and lipoprotein findings seen in subjects with inherited apolipoprotein C-III deficiency

Speaker: Professor C. Ballantyne (Houston, US)

Correlation between different LDL-R mutations and response to ab-PCSK9 therapy in a group of patient with genetic diagnosis of Familial Hypercholesterolemia. Preliminary report.

Speaker: Doctor A. buonaiuto (Naples, IT)

Access the full session

Novel Approaches to Lipid Lowering Therapy

Speakers: Professor G. Watts, Professor C. Ballantyne, Doctor A. buonaiuto

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources